Priya Sachdeva
Stock Analyst at UBS
(3.69)
# 2,093
Out of 5,076 analysts
14
Total ratings
90%
Success rate
25.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Priya Sachdeva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Rated: Buy | $50 | $58.97 | -15.21% | 1 | Jul 28, 2026 | |
| MDT Medtronic | Rated: Hold | $90 → $85 | $95.41 | -10.91% | 2 | Jun 4, 2026 | |
| PEN Penumbra | Downgraded: Hold | $335 → $374 | $324.39 | +15.29% | 7 | Jan 20, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $18 → $22 | $12.91 | +70.41% | 4 | Dec 16, 2025 |
AtriCure
Jul 28, 2026
Rated: Buy
Price Target: $50
Current: $58.97
Upside: -15.21%
Medtronic
Jun 4, 2026
Rated: Hold
Price Target: $90 → $85
Current: $95.41
Upside: -10.91%
Penumbra
Jan 20, 2026
Downgraded: Hold
Price Target: $335 → $374
Current: $324.39
Upside: +15.29%
NeuroPace
Dec 16, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $12.91
Upside: +70.41%